Items where authors include "Herrick, A.L."

Article

Ross, R.L., Caballero-Ruiz, B., Clarke, E.L. et al. (11 more authors) (2024) Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with Very Early Diagnosis of SSc (VEDOSS). Rheumatology. keae698. ISSN 1462-0324

Spierings, J., Welsing, P.M.J., Colak, S. et al. (7 more authors) (2024) Self-reported skin severity and quality of life in systemic sclerosis: multicentre validation of PASTUL. Rheumatology. keae561. ISSN 1462-0324

Chapman, L.S. orcid.org/0000-0002-4207-2809, Alcacer-Pitarch, B. orcid.org/0000-0002-2208-444X, Pauling, J.D. et al. (13 more authors) (2024) Patients’ perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working Group. Seminars in Arthritis and Rheumatism, 65. 152372. ISSN 0049-0172

Tornling, G., Edenius, C., Pauling, J.D. et al. (16 more authors) (2024) A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's. Rheumatology. keae049. ISSN 1462-0324

De Lorenzis, E. orcid.org/0000-0001-9819-105X, Kakkar, V., Di Donato, S. et al. (13 more authors) (2024) Clinical trajectories of hand function impairment in systemic sclerosis: an unmet clinical need across disease subsets. RMD Open, 10 (1). e003216. ISSN 2056-5933

Griffiths-Jones, D.J., Garcia, Y.S., Ryder, W.D. et al. (19 more authors) (2023) A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS). Rheumatology, 62 (9). pp. 3133-3138. ISSN 1462-0324

Griffiths-Jones, D.J., Garcia, Y.S., Ryder, W.D. et al. (19 more authors) (2023) A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS). Rheumatology, 62 (9). pp. 3133-3138. ISSN 1462-0324

Hughes, M., Allanore, Y., Baron, M. et al. (13 more authors) (2022) Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease. The Lancet Rheumatology, 4 (11). e795-e803. ISSN 2665-9913

Peytrignet, S., Denton, C.P., Lunt, M. et al. (60 more authors) (2018) Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study. Rheumatology, 57 (2). pp. 370-381. ISSN 1462-0324

Herrick, A.L., Pan, X., Peytrignet, S. et al. (61 more authors) (2017) Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS). Annals of the Rheumatic Diseases. ISSN 0003-4967

Conference or Workshop Item

Spierings, J., Ong, V.H., Welsing, P.M.J. et al. (5 more authors) (2024) P139 Self-assessment of scleroderma skin: validation of the PASTUL questionnaire. In: British Society for Rheumatology Annual Conference 2024, 24-26 Apr 2024, Liverpool.